Sidera Bio secures DKK 700 million in a Series A biotech round with Novo Holdings, Forbion, RA Capital Healthcare Fund LP, and Gilde Healthcare.
19 November 2025
19 November 2025
Total investments received (USD): 108.5M
Round value (USD): 108.5M
Company: Sidera Bio
Industry: BiotechHealth services
Related deals
Tubulis in germany was acquired by Nasdaq-listed Gilead Sciences for $5 billion, $315B upfront, plus up to $1.85B in contingent milestone payments.
M&A
01 April 2026
Flatpay in a €145 million Series D round with investors including Dawn Capital, AVP and Smash Capital.
Investments
01 November 2025
AAVantgarde Bio to raise $141M series B co-led by Schroders Capital with existing investors Atlas Venture and Forbion
Investments
19 October 2025
Belgium
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal